Adult Stem Cells Scholarly Peer-review Journal
Adult stem
cells are undifferentiated
cells found throughout the body that divide to replenish dying
cells and regenerate damaged tissues. Also referred to as somatic stem cells, they will be found in children, also as adults. Research into adult stem
cells has been fueled by their abilities to divide or self-renew indefinitely and generate all the cell sorts of the organ from which they originate — potentially regenerating the whole organ from a couple of cells. Unlike embryonic stem cells, the utilization of adult stem
cells in research and therapy isn't controversial because the assembly of adult stem
cells doesn't require the destruction of an embryo. Adult stem
cells are often isolated from a tissue sample obtained from an adult. they need mainly been studied in humans and
model organisms like mice and rats. The rigorous definition of a somatic cell requires that it possesses two properties: Self-renewal - the power to travel through numerous cycles of cellular division while maintaining the undifferentiated state. Multipotency or multidifferentiative potential - the power to get progeny of several distinct cell types, for instance both glial
cells and neurons, against unipotency - restriction to a single-cell type. Some researchers don't consider this property essential and believe that unipotent self-renewing stem
cells can exist. somatic cell Treatments thanks to the power of adult stem
cells to be harvested from the patient, their therapeutic potential is that the focus of much research.
High Impact List of Articles
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
Erratum
Erratum: Clinical Investigation
-
Erratum
Erratum: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
Relevant Topics in Clinical